Xconomy | Seattle - Business + Technology in the Exponential Economy

Related Posts

Biotech, vaccines, Flu

IDRI Offers Flu Vaccine Boosters

Luke Timmerman 6/11/09

The Infectious Disease Research Institute, a Seattle-based nonprofit research center, said today it it is offering a critical ingredient to manufacturers that could increase the world supplies of flu vaccine. IDRI has developed adjuvants, or immune-boosting compounds, that make it possible to give smaller doses that can still protect people against infection. The announcement came shortly after the World Health Organization officially declared a global swine flu pandemic.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.

Comments | Reprints | Share:   Retweet Facebook Email

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map Seattle Boston San Diego
national life-sciences startups

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.